Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemafibrate DDI with Clarithromycin
NCT02275988Phase 1Completed
- Start
- Jun 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of pemafibrate in hyperlipidemia (2 arms). Primary endpoint: Maximum concentration at 72 hours. Started Jun 2014; status: completed.
02
Drugs
pemafibrate
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT02275988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02275988.